Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Imaging oxygenation of human tumours.

Padhani AR, Krohn KA, Lewis JS, Alber M.

Eur Radiol. 2007 Apr;17(4):861-72. Review.

2.

PET imaging of tumour hypoxia.

Padhani A.

Cancer Imaging. 2006 Oct 31;6:S117-21. Review. Retraction in: Cancer Imaging. 2007;7:1.

3.

Where are we with imaging oxygenation in human tumours?

Padhani AR.

Cancer Imaging. 2005 Nov 28;5:128-30.

4.

Imaging hypoxia in gliomas.

Mendichovszky I, Jackson A.

Br J Radiol. 2011 Dec;84 Spec No 2:S145-58. doi: 10.1259/bjr/82292521. Review.

5.

Imaging hypoxia in tumours with advanced MRI.

Price JM, Robinson SP, Koh DM.

Q J Nucl Med Mol Imaging. 2013 Sep;57(3):257-70. Review.

6.

Dose prescription and optimisation based on tumour hypoxia.

Toma-Daşu I, Daşu A, Brahme A.

Acta Oncol. 2009;48(8):1181-92. doi: 10.3109/02841860903188643.

PMID:
19863227
7.

Radiolabelled agents for PET imaging of tumor hypoxia.

Kurihara H, Honda N, Kono Y, Arai Y.

Curr Med Chem. 2012;19(20):3282-9. Review.

PMID:
22664246
8.

The meaning, measurement and modification of hypoxia in the laboratory and the clinic.

Hammond EM, Asselin MC, Forster D, O'Connor JP, Senra JM, Williams KJ.

Clin Oncol (R Coll Radiol). 2014 May;26(5):277-88. doi: 10.1016/j.clon.2014.02.002. Review.

9.

Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.

Kim CK, Park SY, Park BK, Park W, Huh SJ.

Eur Radiol. 2014 Jul;24(7):1514-20. doi: 10.1007/s00330-014-3167-0.

PMID:
24763631
10.

Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.

Myerson RJ, Singh AK, Bigott HM, Cha B, Engelbach JA, Kim J, Lamoreaux WT, Moros E, Novak P, Sharp TL, Straube W, Welch MJ, Xu M.

Int J Hyperthermia. 2006 Mar;22(2):93-115.

PMID:
16754595
11.

Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy.

Dalah E, Bradley D, Nisbet A.

Phys Med Biol. 2010 Feb 7;55(3):681-94. doi: 10.1088/0031-9155/55/3/009.

PMID:
20071761
12.

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.

Bourgeois M, Rajerison H, Guerard F, Mougin-Degraef M, Barbet J, Michel N, Cherel M, Faivre-Chauvet A.

Nucl Med Rev Cent East Eur. 2011;14(2):90-5. Review.

13.

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1171-82.

PMID:
11240261
14.

Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.

Bonnitcha PD, Bayly SR, Theobald MB, Betts HM, Lewis JS, Dilworth JR.

J Inorg Biochem. 2010 Feb;104(2):126-35. doi: 10.1016/j.jinorgbio.2009.10.009.

15.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.

O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502.

PMID:
15817355
16.

Rapid dual-tracer PTSM+ATSM PET imaging of tumour blood flow and hypoxia: a simulation study.

Rust TC, Kadrmas DJ.

Phys Med Biol. 2006 Jan 7;51(1):61-75.

PMID:
16357431
17.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
18.

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M.

J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033.

19.

Imaging tumour hypoxia with positron emission tomography.

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, Domarkas J, Lord S, Baldry C, Gilbert FJ.

Br J Cancer. 2015 Jan 20;112(2):238-50. doi: 10.1038/bjc.2014.610. Review.

20.

The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.

Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, Carson J, Sowers AL, English S, Green MV, Bacharach SL, Eckelman WC, Mitchell JB.

Int J Oncol. 2007 Apr;30(4):873-81.

PMID:
17332926

Supplemental Content

Support Center